Arbutus to repurchase up to $230M of shares in tender offer

What to know

  • Arbutus to repurchase up to $230M of shares in tender offerS1
  • WARMINSTER, Pa., Aug. 21, 2026 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced plans to commence a modified “Dutch Auction”...S2
Timeline · newest first
2mos Business

Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer

WARMINSTER, Pa., Aug. 21, 2026 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on i…

Arbutus to repurchase up to $230M of shares in tender offer

2 outlets 2 reports

What to know

  • Arbutus to repurchase up to $230M of shares in tender offerS1
  • WARMINSTER, Pa., Aug. 21, 2026 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced plans to commence a modified “Dutch Auction”...S2
Timeline · newest first

Sources · 2 citations

S1 Seekingalpha 1 report · EN
S2 BusinessLead 1 report · EN